In addition, using pharmacological inhibition and genetic depletion approaches, we formally identified ADAM10 and ADAM17 as the targeted proteases, thereby establishing WNF as a potent α-secretase enhancer and a possible anti-AD agent. The gene discussed is ADAM17; the disease is Alzheimer disease.